Skip to main content
Equibles

Y-Intercept (Hong Kong) Ltd

Position in RAPP — Rapport Therapeutics, Inc.

CIK 1772875 HONG KONG, K3
Back to RAPP Full portfolio

Position in RAPP

as of Jun 30, 2026 · filed Jul 14, 2026
Position Value
$799,605
-$321,359 QoQ
Shares Held
19,189
-46.4% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#80
of 159 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $205,108,253 across 117 Biotechnology names. RAPP ranks #65 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 101,908 $10,865,430
2 MRNA
Moderna, Inc.
 139,861 $9,794,465
3 BBIO
BridgeBio Pharma, Inc.
 107,419 $8,000,567
4 AXSM
Axsome Therapeutics, Inc.
 22,923 $5,610,862
5 IONS
Ionis Pharmaceuticals Inc
 67,374 $5,342,084
6 ADMA
Adma Biologics, Inc.
 573,581 $4,800,872
7 UPB
Upstream Bio, Inc.
 693,555 $4,799,400
8 NRIX
Nurix Therapeutics, Inc.
 192,434 $4,668,448

All Filings in RAPP

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $799,605 19,189
2026-03-31 $1,120,964 35,825